Live Attenuated Coronavirus Vaccines

Posted September 18, 2012 - 1:37pm

The present invention is directed live, attenuated coronavirus vaccines. The vaccine comprises a viral genome encoding a p59 protein having at mutation at a specific tyrosine residue, and may include other attenuating mutations. Such viruses show reduced growth and pathogenicity in vivo.

Website
U.S. Patent 7,452,542: Live attenuated coronavirus vaccines

Inventors: 

Mark Denison

Licensing manager: 
Mike Villalobos
mike.villalobos@vanderbilt.edu

Featured Video

2012 Highlights

A motion graphic video describing operational improvements and successes of FY2012. Click here for a full PDF report.